Cambridge, Mass. and Singapore – Cirrus Therapeutics today announced several business and pipeline updates to support its growth as a leading global ocular immunology company advancing first-in-class and best-in-class therapies to extend the ocular healthspan of patients with chronic blinding diseases. “Our presence in Singapore well positions us to leverage critical research, clinical development and partnering […]
